Sökresultat

This article is over 5 years old, and the information may therefore be outdated. A new COVID-19 antibody test developed by scientists at Lund University in Sweden has shown robust performance upon clinical validation and application. The test detects antibodies in the blood targeting the spike protein of SARS-CoV-2, and determines in just 15 minutes whether a person has had COVID-19, regardless of

https://www.ludc.lu.se/article/new-rapid-and-robust-covid-19-antibody-test-developed - 2026-04-19

This article is over 5 years old, and the information may therefore be outdated. Last week it was announced that our longtime colleague and LUDC researcher/SUS clinician Martin Ridderstråle has been appointed Senior Vice President of Patient Care in the Novo Nordisk Foundation. This is not only a remarkable achievement by Martin but also goes to show that our environment fosters excellent scientis

https://www.ludc.lu.se/article/senior-vice-president-patient-care-novo-nordisk-foundation - 2026-04-19

Karl Bacos, assistant researcher at LUDC is the recipient of 2020 years Medeon stipend of 50 000 sek for his innovative work within epigenetics in diabetes.   The Medeon stipend is handed out in connection to the acknowledgement of World Diabetes Day in Skåne which takes place on November 14th. This year the arrangement will be broad casted to the public in real time from Medeon Science Park in Ma

https://www.ludc.lu.se/article/karl-bacos-years-recipient-medeon-stipend - 2026-04-19

This article is over 5 years old, and the information may therefore be outdated. In many studies, bariatric surgery has been highlighted as an almost magical method for weight loss and reversing type 2 diabetes. One question that has remained largely unanswered is how the effect of surgery differs from the effects of a strict low-calorie diet. This question has now been examined by researchers at

https://www.ludc.lu.se/article/strict-diet-explains-metabolic-effect-gastric-pass-surgery - 2026-04-19

This article is over 5 years old, and the information may therefore be outdated. Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects, which is the reason many choose to stop medicating. Researchers at Lund University in Sweden have now identified bi

https://www.ludc.lu.se/article/metformin-type-2-diabetes-patients-or-not-researchers-now-have-answer - 2026-04-19

Should patients with separate variants of type 2 diabetes be treated with different types of drugs? Researchers at Lund University in Sweden and Skåne University Hospital will attempt to answer that question in a new study.   Type 2 diabetes is one of the fastest growing diseases in the world. It is estimated that over 300 million people have the disease globally. “Current treatment methods are un

https://www.ludc.lu.se/article/new-study-personalized-type-2-diabetes-treatment-launched - 2026-04-19

This article is over 5 years old, and the information may therefore be outdated. Our latest study on COVID-19 transmission risk among healthcare professionals, a collaboration between Prof Magnus Rasmussen (Dep. of Infection Medicine) and Associate Professor Yang De Marinis (Dep. of Clinical Sciences).  The study was conducted on ~500 healthcare professionals and staff members from 9 units at the

https://www.ludc.lu.se/article/study-covid-19-among-healthcare-professionals - 2026-04-19

Newborn babies are already being screened for mutations and genetic tests help families with hereditary breast cancer. Genomic-driven precision medicine (GDPM) is an emerging approach for disease treatment. Around 30 Swedish researchers suggest a direction forward in a review article in Journal of Internal Medicine (JIM). "At the moment newborns are screened for a small number of mutations. In the

https://www.ludc.lu.se/article/precision-medicine-emerging-approach-complex-diseases - 2026-04-19

During the pandemic, the free COVID Symptom Study app has helped researchers understand the complexity and spread of the corona virus better. “The study has exceeded our expectations since its launch in Sweden in April 2020. Participants from all over Sweden got involved and many of them have spent one minute every day answering questions about their health”, says Maria Gomez, Professor of physiol

https://www.ludc.lu.se/article/study-tracks-spread-covid-19-sweden - 2026-04-19

Researchers from Lund University Diabetes Centre (LUDC) receive 5,3 million SEK in grants from the Crafoord Foundation in southern Sweden. This year, 15 researchers from LUDC are awarded grants for a wide range of projects in diabetes research. In total, researchers at LUDC receive 5,3 million SEK in grants from the foundation. – It is great news and an important contribution to support projects s

https://www.ludc.lu.se/article/15-researchers-lund-university-diabetes-centre-receive-millions-funding - 2026-04-19

Type 2 diabetes is a complex disease that can lead to serious health problems. It is important to find ways to predict the disease to take preventive measures. A large interdisciplinary study led by Lund University has identified a biomarker in the blood that predicts type 2 diabetes several years before diagnosis. Diabetes is on the rise and over time, diabetes can lead to complications such as c

https://www.ludc.lu.se/article/blood-biomarker-identified-predicts-type-2-diabetes-several-years-diagnosis - 2026-04-19

Diabetes researchers have established methods for screening people with an increased risk of developing type 1 diabetes. Current methods require multiple blood samples during each visit. An international team of researchers has developed a simplified screening method, which will increase screening efficiency. Type 1 diabetes is a disease that requires lifelong treatment with insulin. People of all

https://www.ludc.lu.se/article/improved-screening-efficiency-type-1-diabetes-simplified-blood-draw - 2026-04-19

Three researchers at Lund University Diabetes Centre (LUDC) receive generous grants from the Hjelt Diabetes Foundation in 2021. Ola Hansson, Karl Bacos and Malin Fex have been awarded 45 000 euros each for their research projects. A common aim is to develop a better understanding of the mechanisms behind type 2 diabetes. Diabetes has become a major health issue with nearly half a billion people li

https://www.ludc.lu.se/article/hjelt-foundation-grants-mechanistic-studies-type-2-diabetes - 2026-04-19

Metformin is often described as the first-line medication for the treatment of type 2 diabetes. However, not all patients respond to the drug. Researchers at Lund University have discovered a combination of biomarkers that can predict which patients will benefit from the treatment. This work is now continuing in order to confirm the results in a larger patient group, with the intention of developi

https://www.ludc.lu.se/article/diabetes-research-collaboration-can-pave-way-innovation - 2026-04-19

Emily Sonestedt investigates how food affects the health and the risk to develop type 2 diabetes. This knowledge is of importance to society when developing food-based dietary guidelines. It can be hard to make healthy food choices. The bread rolls behind the counter in the café at Clinical Research Centre (CRC) in Malmö have a dark color, but it does not have to mean that they are a healthy choic

https://www.ludc.lu.se/article/healthy-eating-reduce-risk-type-2-diabetes - 2026-04-19

Identical twins share the same DNA, but one twin may suffer from type 2 diabetes while the other twin does not develop the disease. A study led by Lund University in Sweden has now discovered that there are differences in gene activity in twins where only one sibling had developed the disease. The researchers’ discovery could contribute to the development of new treatment methods. “Identical twins

https://www.ludc.lu.se/article/twin-study-finds-type-2-diabetes-clues-epigenetic-changes - 2026-04-19

Charlotte Ling, a professor of epigenetics and diabetes at Lund University, has been awarded a distinguished professor grant in medicine and health by the Swedish Research Council.  The grant of 50 million SEK over a period of ten years will allow Charlotte Ling to develop the research environment within epigenetics and diabetes at Lund University Diabetes Centre (LUDC).  “I am very grateful for t

https://www.ludc.lu.se/article/distinguished-professor-grant-researcher-epigenetics-and-diabetes - 2026-04-19

A lot of research explains which diets may reduce the risk of developing type 2 diabetes. Much research remains to be done about how our genes respond to the foods we eat. A new study led by researchers at Lund University adds to evidence that variations in the AMY1 gene may affect the way the body breaks down starchy foods. Unhealthy food habits are risk factors for developing type 2 diabetes. An

https://www.ludc.lu.se/article/bread-study-examines-role-genes-breaking-down-food - 2026-04-19

Previous research from Lund University has shown that diabetes can be divided into five groups with different disease progression. A new study published in Nature Genetics demonstrates that there are also genetic differences between different groups of patients. An important goal of the research is to contribute with knowledge that will enable tailored treatments of patients with type 2 diabetes.

https://www.ludc.lu.se/article/new-research-highlights-genetic-differences-between-different-forms-type-2-diabetes - 2026-04-19

The fourth Swedish diabetes summit will be held as an online meeting on the 10th and 11th of February. The meeting brings together diabetes researchers in Sweden for new interactions and collaborations. “We aim to create an inspiring meeting where diabetes researchers can interact and form new collaborations,” says Hindrik Mulder, professor of metabolism at Lund University and chair of the organis

https://www.ludc.lu.se/article/swedish-diabetes-summit-brings-together-diabetes-researchers-new-collaborations - 2026-04-19